The tissue distribution and levels of estrogen receptor in neonatal mouse uterine tissue were determined in epithelial and stromal fractions separated by mild enzymatic treatment. Proteins of the isolated fractions were separated by gel electrophoresis and receptor was detected on immunoblots with monoclonal antibody H-222. Estrogen receptor protein was detectable in samples of reproductive tract tissue from 5-and 10-day-old mice. The level of receptor in 5-day-old animals was lower per unit DNA in epithelial cells than in stroma.
bind steroid as evidenced by affinity labeling with tamoxifen aziridine. Immunohistochemistry on sections of uteri from 4-and 10-day-old mice confirmed the biochemical results and indicated lower nuclear straining in epithelial cells than in stromal cells of uteri of 4-day-old mice. These results demonstrated that estrogen receptor protein is present in both epithelium and stroma of the neonatal mouse uterus, but at a higher level in stromal cells.
Exposure to estrogenic agents during development of the reproductive tract in fetal or neonatal life results in the expression of aberrant phenotype and possibly cancer (1) . One of the best experimental models for studying these effects is the mouse reproductive tract, in which uterine adenocarcinoma similar to that seen in human subjects can be induced (2) . The mechanism for the expression of these lesions is not well understood, although it is clear that hormonally active agents are the prime effectors. Initiation of this carcinogenicity is believed to be a result of the hormonal activity ofthe compound mediated through a receptor protein mechanism, which results in hypertrophy and hyperplasia of the tissue (3) . On the other hand, the event may be independent of the hormonal activity and follow a pattern seen for chemical carcinogens involving metabolic activation and irreversible macromolecular binding. Evidence to argue against the receptor and hormonal activity hypothesis was found from steroid autoradiography studies indicating that epithelial cells of the neonatal reproductive tract lacked estrogen receptors (4) . However, these cells exhibit DNA synthesis after exposure to estrogens (5) , suggesting that the growth responses in the uterine epithelium of neonatal mice may not be mediated by estrogen receptors. Such findings are important since they counter the hypothesis that the carcinogenicity is an estrogen-specific process governed by receptor binding. Alternatively, some of the estrogen receptor responses such as growth stimulation may not be receptor mediated but may occur through other cellular reactions.
In an attempt to understand the intracellular mechanisms of estrogen action and specificity toward the onset of toxicity/carcinogenicity in the reproductive tract, we have investigated the cell-specific presence of the estrogen receptor by using monoclonal antibody H-222 to the estrogen receptor protein (6) . This approach was taken to eliminate problems that could occur involving detection sensitivity by autoradiographic techniques in certain cell types such as the epithelium. We used two approaches: (i) separation and isolation of uterine epithelial cells and biochemical analysis of receptor protein from these tissues by immunochemistry and ligand affinity labeling, and (it) immunohistochemical detection of the receptor protein within specific cell types of the neonatal reproductive tract.
MATERIALS AND METHODS
Animals and Tissue Preparation. Mice (CD-1:CRL) were obtained from the National Institute of Environmental Health Sciences breeding colony and weaned just prior to sacrifice or treatment. Animals were killed and reproductive tracts were removed and placed in F-12 medium/Dulbecco's modified Eagle's medium phenol red-free medium. Tracts were rinsed with fresh medium and epithelial and stromal tissues were separated as described (7 (8) . Protein concentrations were measured by the Bradford method (9) using rabbit immunoglobulin as the standard. DNA was measured as described (10) with calf thymus DNA as a standard. Pure mouse a-fetoprotein was a gift of George Mizejenski (New York State Laboratories, Albany, NY). Gel samples were transferred to nitrocellulose sheets by diffusion blotting (8) and probed with a monoclonal antibody (H-222) to the estrogen receptor, which was a gift from Chris Nolan (Abbott) (6) .
Epithelial Cell Isolation. Epithelial cells were isolated as reported (7) with the following modifications. The concentration of trypsin used for tissue separations from 5-and 10-day-old animals was reduced from 0.5% to 0.1%, and the trypsin incubation was terminated by addition of medium containing soybean trypsin inhibitor (10 ug/ml). The epithelial fragments were separated under a dissecting microscope to eliminate nonepithelial fragments from the preparation. To avoid possible loss of epithelial cells from tissues of the younger mice, the Percoll gradient centrifugation step was eliminated. Fibroblastic cell outgrowth was rare in the epithelial preparations, indicating that they were relatively pure (unpublished observation).
Immunohistochenistry. Uteri were removed from 4-dayold mice and fixed with ice-cold 3.7% formaldehyde (1 vol of 37% formaldehyde solution and 9 vol of 0.1 M phosphate buffer, pH 7.2) for 1 hr. The tissue was washed overnight at 40C in phosphate-buffered saline (PBS) containing 7.5% sucrose, embedded in O.C.T. compound (Ames, Elkhart, IN) and frozen in acetone on dry ice. Cryostat sections (-4 ,um thick) were incubated with 1% bovine serum albumin in PBS for 30 min to reduce background staining. Sections were treated with primary antibody ofAbbott ER-ICA monoclonal antibody kit (Abbott), which was diluted 1:2 with 2% bovine serum albumin in PBS. After washing in PBS, sections were incubated for 45 min with peroxidase-labeled F(ab')2 [HRP-F(ab')2] prepared from sheep IgG antibody to rat immunoglobulin (Amersham). To minimize nonspecific binding, HRP-F(ab')2 was diluted 50 times with 1% bovine serum albumin in PBS containing (each at 20 Ag/ml) antipain, chymostatin, and leupeptin, and then acetone powder of mouse liver was added to the solution for a final concentration of 50 mg/ml. The mixture was shaken gently overnight at 4°C and centrifuged for 5 min at 10,000 x g. The supernatant was filtered through a 0.22-,um Millex filter (Millipore) before use.
Tissue sections were next incubated with imidazol-3,3'-diaminobenzidine tetrahydrochloride (DAB) solution according to the method of Straus (11) . The DAB reaction was carried out for 10-30 min; then the sections were washed with distilled water, dehydrated with ethanol, cleared with xylene, and mounted in balsam.
RESULTS
Uterine tissues were separated into epithelial cell contents and stromal fractions and analyzed by NaDodSO4/PAGE and immunoblots were probed with monoclonal antibody H-222 or normal rat serum. Fig. 1 (8) . It is possible that a-fetoprotein may be present in these neonatal mice. Because a-fetoprotein has a molecular mass similar to that of the estrogen receptor and is also capable of binding steroids (see Fig. 3 labeled with [3H]tamoxifen aziridine proteins separated by NaDodSO4/PAGE and gels were analyzed by fluorography (Fig. 3) . Partially purified receptor was affinity-labeled and analyzed concomitantly at concentrations of 1-16 ng (lanes 9-13). All banding in the partially purified preparations marked by arrows was competible and displaceable with unlabeled DES. A nondisplaceable band is marked by the asterisk at 42 kDa. The day-5 samples (lanes 1-4) indicate a labeled receptor form (heavy arrow) at 65 kDa in samples from both epithelium and stroma. This receptor form is more abundant in the stroma than in epithelium. These results are similar to those shown by immunoblotting in Fig. 1 3 and 4) . Day-10 uterine epithelium and stroma, which were affinity-labeled, are shown in lanes 5-8. Specific nondisplaceable labeled receptor forms are seen in both samples. Interestingly, there are three additional smaller forms seen in both samples. Two forms correspond to proteolytic fragments seen in partially purified estrogen receptor preparations of54 and 37 kDa (8) . The third is similar to the 26-kDa band shown by immunochemical analysis in Fig. 1 . It is apparent, particularly in data from day-5 mice shown here and day-4 mice (not presented), that the epithelial samples have a ligand-binding component that could produce a very high nondisplaceable background. Only by electrophoretic separation of the sample proteins can the displaceable specific binding component in the sample be detected.
Immunohistochemistry was used to confirm the biochemical observations by using a modification procedure with the Abbott ER-ICA monoclonal antibody kit. The pattern of immunostaining in uteri from day-4 mice is shown in Fig. 4 (Upper). Strong staining was seen in stromal cells, as ex- pected from the biochemical analyses. The staining was uniform throughout the stroma with all cells showing similar localization in nuclei. Compared to the stromal cells, the epithelial cells did not show a uniform immunostaining pattern. The staining in epithelial cell nuclei was random and showed a range of staining intensity that comprised 27% ± 3% of the epithelial cell population. In all cases, the nuclear epithelial cell staining was less intense than in stromal cells. These (14) . Most interesting of our results were the distribution and levels of estrogen receptor in the epithelium of 4-to 5-day neonates. In the past, biochemical studies have used tissue homogenates and cell mixtures to determine receptor levels under a variety of experimental paradigms. Quantification of estrogen receptor levels and normalization per unit DNA have then been used to estimate the number of sites per cell (3) . Such an approach may be misleading in neonates since per unit DNA the levels of estrogen receptor in epithelial cells are lower than stroma. The developmental pattern indicates the amount of estrogen receptor progressively increases, and by 15 days of age, levels in the epithelium and stroma are similar (S.Y., R.R.N., J.A.M, and K.S.K., unpublished data). Moreover, epithelial estrogen receptor expression is advanced by treatment with estrogen and thus is present prematurely in epithelial tissues (R.R.N., S.Y., K.S.K., and J.A.M., unpublished data). Thereby, the continued exposure of fetal or neonatal animals to estrogen, which results in toxicity of the reproductive tract, would result in estrogen receptor expression in affected tissues.
This study illustrates, with development of techniques and reagents such as the estrogen receptor antibody, that past questions regarding receptor protein localization and quantity may require reevaluation to determine whether a small group of cells are present that possess the receptor components. Accordingly, a small group of cells possessing the receptor protein may be the site of origin and govern the target site specificity for the toxicity. This is not unlike earlier studies indicating that the cell of origin for mammary carcinoma is the intermediate cell (15) . Only with the advent of a marker for early cellular carcinogenicity and its correlation to the cellular presence of estrogen receptor protein can a direct relationship be developed.
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